Plexus Corp. (PLXS)

We adjust our F2025/F2026E (Sept) EPS for Plexus (PLXS; $118.29; E/W) from $7.05/$7.70 to $7.20/$7.40 after it produced FQ3 (Jun) EPS upside, albeit on as expected operating profits, but with FQ4E (Sept) guidance that was…

Plexus (PLXS; $133.83; E/W) reported FQ3 (Jun) non-GAAP EPS of $1.90, which was ahead of our $1.73 and the Street’s $1.71, albeit on some lower-than-expected sales ($1,018mm vs. our $1,025mm and the Street’s $1,021mm) and…

We do not expect meaningful changes to our F2025/F2026E (Sep) EPS for Plexus (PLXS; $133.11; E/W) after its FQ3E (Jun) results and guidance on Wednesday, July 23rd (after market). To that end, we model F2025/F2026E…

Last night, Plexus (PLXS; $132.09; E/W) announced that its Board authorized a $100mm increase to its share repurchase program. By comparison, PLXS’ market cap is $3.7B and the company disclosed that it had $18mm remaining…

We bump up our F2025/F2026E (Sept) EPS for Plexus (PLXS; $125.35; E/W) from $6.90/$7.55 to $7.05/$7.70 after the company produced some FQ2 (Mar) EPS upside, led by healthier than expected operating margins, and FQ3E (Jun)…

Plexus (PLXS; $127.17; E/W) reported FQ2 (Mar) non-GAAP EPS of $1.66, comfortably beating our consensus matching $1.54, on sales of $980mm, which was basically in line with the Street’s $981mm and slightly below our more…

We assume Plexus’ (PLXS; $121.28; E/W) relative mix of served market exposure and global footprint proves new tariffs to be less of an issue for the company relative to others we follow in the supply…

Yesterday (3/19), we hosted investor meetings for Plexus (PLXS; $127.26; E/W) that included CEO Todd Kelsey plus Mike Running, President, Americas and Shawn Harrison, VP of IR. Overall, management seems to still be basing its…

We raise our F2025/F2026E (Sept) EPS from $6.60/$7.25 to $6.90/$7.55 for Plexus (PLXS; $153.30; E/W) after the company produced some solid FQ1 (Dec) operating results while offering up FQ2E (Mar) guidance that was in line…

Plexus (PLXS; $170.49; E/W) reported FQ1 (Dec) non-GAAP EPS of $1.73, which beat our $1.60 and the Street’s $1.59 despite somewhat lower-than-expected sales ($976mm vs. our $988mm and the Street’s $982mm) that resulted in as…

We adjust our F2025E (Sep) EPS for Plexus (PLXS; $145.42; E/W) from $6.50 to $6.60 (+15% YoY vs. -11% in F2024) after a healthy FQ4 (Sep) beat, predominantly driven by better-than-expected quarter-end production activity that…

Plexus (PLXS; $135.57; E/W) reported FQ4 (Sep) non-GAAP EPS of $1.85, which was well ahead of our $1.58 and the Street’s $1.55, albeit including $0.12 per share of more favorable non-operating items than was considered…

We have badly missed a recent breakout in the shares of Plexus (PLXS; $136.69; E/W) since its most recent bottom in mid-June (e.g., +34% since 6/11 vs. +21% over the prior two years), which especially…

We raise our F2024/F2025E (Sep) EPS for Plexus (PLXS; $129.59; E/W) from $5.10/$6.20 to $5.45/$6.50 after the company produced a healthy FQ3 (Jun) beat and FQ4E (Sep) guidance that exceeded our prior thinking. Specifically, FQ3…

Plexus (PLXS; $116.15; E/W) reported FQ3 (Jun) non-GAAP EPS of $1.45, which beat our $1.30 on some better-than-expected operating profits and margins (5.8% of sales vs. our 5.4%) despite some lower-than-expected sales ($961mm vs. our…